Vaxart Inc. announced that it has received a delisting notice from The Nasdaq Stock Market due to its failure to meet the minimum bid price requirement of $1.00 per share for its common stock. Despite being granted an additional compliance period until June 30, 2025, the company was unable to regain compliance. Consequently, Vaxart's stock is set to be delisted, with trading to be suspended on July 8, 2025. The company plans to transition its stock to the over-the-counter market under the symbol "VXRT" and has applied to be traded on the OTCQX tier, although approval is not guaranteed.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxart Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-021865), on July 02, 2025, and is solely responsible for the information contained therein.